Terms: = Breast cancer AND HER1, YOR227W AND Diagnosis
10 results:
1. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
Yue L; Wentao L; Xin Z; Jingjing H; Xiaoyan Z; Na F; Tonghui M; Dalin L
Medicine (Baltimore); 2020 Dec; 99(51):e23406. PubMed ID: 33371069
[TBL] [Abstract] [Full Text] [Related]
2. Emerging ways to treat breast cancer: will promises be met?
Samadi P; Saki S; Dermani FK; Pourjafar M; Saidijam M
Cell Oncol (Dordr); 2018 Dec; 41(6):605-621. PubMed ID: 30259416
[TBL] [Abstract] [Full Text] [Related]
3. [Carcinosarcoma of the breast a rare entity with fatal prognosis. One case report].
Villalón-López JS; Souto-del Bosque R; Alonso-Briones MV; Trujillo-de Anda AP
Cir Cir; 2013; 81(4):328-32. PubMed ID: 25063898
[TBL] [Abstract] [Full Text] [Related]
4. Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.
Bartlett JM; Brookes CL; Piper T; van de Velde CJ; Stocken D; Lyttle N; Hasenburg A; Quintayo MA; Kieback DG; Putter H; Markopoulos C; Kranenbarg EM; Mallon EA; Dirix LY; Seynaeve C; Rea DW
Br J Cancer; 2013 Oct; 109(9):2453-61. PubMed ID: 24091623
[TBL] [Abstract] [Full Text] [Related]
5. Association between mammographic density and basal-like and luminal A breast cancer subtypes.
Razzaghi H; Troester MA; Gierach GL; Olshan AF; Yankaskas BC; Millikan RC
Breast Cancer Res; 2013; 15(5):R76. PubMed ID: 24008056
[TBL] [Abstract] [Full Text] [Related]
6. HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.
Chiu CG; Masoudi H; Leung S; Voduc DK; Gilks B; Huntsman DG; Wiseman SM
Ann Surg; 2010 Jun; 251(6):1107-16. PubMed ID: 20485140
[TBL] [Abstract] [Full Text] [Related]
7. Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.
Vollmann-Zwerenz A; Diermeier-Daucher S; Wege AK; Sassen A; Schmidt-Brücken E; Hofstaedter F; Ortmann O; Nauwelaers F; Brockhoff G
Cytometry A; 2010 Apr; 77(4):387-98. PubMed ID: 20151455
[TBL] [Abstract] [Full Text] [Related]
8. Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Yang XR; Sherman ME; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Anderson WF; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Cartun R; Mandich D; Rymkiewicz G; Ligaj M; Lukaszek S; Kordek R; García-Closas M
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):439-43. PubMed ID: 17372238
[TBL] [Abstract] [Full Text] [Related]
9. Metaplastic breast cancer: clinical significance.
Beatty JD; Atwood M; Tickman R; Reiner M
Am J Surg; 2006 May; 191(5):657-64. PubMed ID: 16647355
[TBL] [Abstract] [Full Text] [Related]
10. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Leibl S; Moinfar F
Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
[TBL] [Abstract] [Full Text] [Related]
